Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Searches
(0)
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Online First
Supplements
NCCN Meeting Highlights
JNCCN In the News
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside
Search
Close
Advanced Search
Help
Volume 12 (2014): Issue 11 (Nov 2014)
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Get eTOC Alerts
Get Ahead of Print Alerts
Citation Alert
NCCN News
Pages: xxx–xxxii
Oncology Research Program
Pages: xlii
Bringing Science to Clinical Practice
By:
Margaret Tempero
Pages: 1495
Colon Cancer: The New Chronic Disease
By:
Al B. Benson III
Pages: 1497–1499
Thymoma Complicated by Acquired Amegakaryocytic Thrombocytopenia and Pure Red Cell Aplasia
By:
Carl M. Gay
,
William N. William Jr
,
Sa A. Wang
and
Thein Hlaing Oo
Pages: 1505–1509
Lung Stereotactic Body Radiotherapy for Early-Stage NSCLC in Patients With Prior Pneumonectomy: A Case Report
By:
Daniel R. Simpson
,
Parag Sanghvi
and
Ajay P. Sandhu
Pages: 1513–1516
Central Nervous System Cancers, Version 2.2014
By:
Louis Burt Nabors
,
Jana Portnow
,
Mario Ammirati
,
Henry Brem
,
Paul Brown
,
Nicholas Butowski
,
Marc C. Chamberlain
,
Lisa M. DeAngelis
,
Robert A. Fenstermaker
,
Allan Friedman
,
Mark R. Gilbert
,
Jona Hattangadi-Gluth
,
Deneen Hesser
,
Matthias Holdhoff
,
Larry Junck
,
Ronald Lawson
,
Jay S. Loeffler
,
Paul L. Moots
,
Maciej M. Mrugala
,
Herbert B. Newton
,
Jeffrey J. Raizer
,
Lawrence Recht
,
Nicole Shonka
,
Dennis C. Shrieve
,
Allen K. Sills Jr
,
Lode J. Swinnen
,
David Tran
,
Nam Tran
,
Frank D. Vrionis
,
Patrick Yung Wen
,
Nicole R. McMillian
and
Maria Ho
Pages: 1517–1523
Survivorship: Screening for Cancer and Treatment Effects, Version 2.2014
By:
Crystal S. Denlinger
,
Jennifer A. Ligibel
,
Madhuri Are
,
K. Scott Baker
,
Wendy Demark-Wahnefried
,
Don Dizon
,
Debra L. Friedman
,
Mindy Goldman
,
Lee Jones
,
Allison King
,
Grace H. Ku
,
Elizabeth Kvale
,
Terry S. Langbaum
,
Kristin Leonardi-Warren
,
Mary S. McCabe
,
Michelle Melisko
,
Jose G. Montoya
,
Kathi Mooney
,
Mary Ann Morgan
,
Javid J. Moslehi
,
Tracey O’Connor
,
Linda Overholser
,
Electra D. Paskett
,
Jeffrey Peppercorn
,
Muhammad Raza
,
M. Alma Rodriguez
,
Karen L. Syrjala
,
Susan G. Urba
,
Mark T. Wakabayashi
,
Phyllis Zee
,
Nicole R. McMillian
and
Deborah A. Freedman-Cass
Pages: 1526–1531
Solid Malignancies in Individuals With Down Syndrome: A Case Presentation and Literature Review
By:
Scott V. Bratman
,
Kathleen C. Horst
,
Robert W. Carlson
and
Daniel S. Kapp
Pages: 1537–1545
Predictors of Outcome in Bladder Cancer
By:
John B. Eifler
,
Daniel A. Barocas
and
Matthew J. Resnick
Pages: 1549–1554
Approach to the Management of Incidental Venous Thromboembolic Events in Patients With Cancer
By:
Casey L. O’Connell
and
Howard A. Liebman
Pages: 1557–1560
Role of MRI in Primary Brain Tumor Evaluation
By:
Denise Leung
,
Xiaosi Han
,
Tom Mikkelsen
and
L. Burt Nabors
Pages: 1561–1568
Timing of Initial Antibiotic Treatment for Febrile Neutropenia in the Emergency Department: The Need for Evidence-Based Guidelines
By:
Demetrios N. Kyriacou
,
Borko Jovanovic
and
Olga Frankfurt
Pages: 1569–1573
Socioeconomic and Clinical Factors Are Key To Uncovering Disparity in Accrual Onto Therapeutic Trials for Breast Cancer
By:
Carolyn E. Behrendt
,
Arti Hurria
,
Lusine Tumyan
,
Joyce C. Niland
and
Joanne E. Mortimer
Pages: 1579–1585
Chronic Myelogenous Leukemia, Version 1.2015
By:
Susan O’Brien
,
Jerald P. Radich
,
Camille N. Abboud
,
Mojtaba Akhtari
,
Jessica K. Altman
,
Ellin Berman
,
Peter Curtin
,
Daniel J. DeAngelo
,
Michael Deininger
,
Steven Devine
,
Amir T. Fathi
,
Jason Gotlib
,
Madan Jagasia
,
Patricia Kropf
,
Joseph O. Moore
,
Arnel Pallera
,
Vishnu VB. Reddy
,
Neil P. Shah
,
B. Douglas Smith
,
David S. Snyder
,
Meir Wetzler
,
Kristina Gregory
and
Hema Sundar
Pages: 1590–1610
Where Exactly Does Ponatinib Fit in Chronic Myelogenous Leukemia?
By:
Ellin Berman
Pages: 1615–1620
NCCN Working Group Report: Designing Clinical Trials in the Era of Multiple Biomarkers and Targeted Therapies
By:
Alan P. Venook
,
Maria E. Arcila
,
Al B. Benson III
,
Donald A. Berry
,
David Ross Camidge
,
Robert W. Carlson
,
Toni K. Choueiri
,
Valerie Guild
,
Gregory P. Kalemkerian
,
Razelle Kurzrock
,
Christine M. Lovly
,
Amy E. McKee
,
Robert J. Morgan
,
Anthony J. Olszanski
,
Mary W. Redman
,
Vered Stearns
,
Joan McClure
and
Marian L. Birkeland
Pages: 1629–1649
On Mentorship: Lessons From My Father
By:
Barbara Burtness
Pages: 1651–1652
Collapse
Expand
Search
Issue
Journal
[34.204.185.54]
34.204.185.54
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
